Starting a Benzodiazepine Taper Conversation: The Dose Hasn’t Changed, but the Clinical Picture Has

Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

A benzodiazepine prescription can remain unchanged for years while the clinical picture around it changes. In this case excerpt, a patient has taken the same clonazepam dose responsibly for more than a decade, but sleep apnea, fatigue, memory concerns, fall risk, alcohol exposure, and improved treatment of his underlying anxiety have created new reasons to reconsider the regimen.

This episode looks at how to decide whether those changes justify attempting a taper, how to explain the recommendation without blaming the patient or dismissing the medication’s prior benefit, and why starting the conversation does not require reducing the dose that day or committing to a predetermined endpoint.

Visit the episode page for the key clinical takeaways and the downloadable Benzodiazepine Prescription Review—a two-page clinical tool for clarifying what the medication is doing, what may have changed, what needs stabilization, and what the next treatment goal should be. The download is available with a free Collaborative Psychiatry account.

For the complete case—including what happens after the first conversation, how the taper is adjusted, and how the eventual endpoint is decided—explore Benzodiazepines in the Grey Zone: A Case Series + Clinical Toolkit.

You can also browse more Collaborative Psychiatry QuickTakes.